Source: Virtual Congress 2021 – From phenotyping to different diagnostic tools for sleep breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
I. Bouloukaki (Heraklion (Crete), Greece), M. Bonsignore (Palermo, Italy), L. Grote (Gothenburg, Sweden), W. Mcnicholas (Dublin, Ireland), J. Hedner (Gothenburg, Sweden), J. Verbraecken (Antwerp, Belgium), S. Ryan (Dublin, Ireland), C. Lombardi (Milan, Italy), O. Basoglu (Izmir, Turkey), A. Pataka (Thessaloniki, Greece), F. Fanfulla (Pavia, Italy), S. Bailly (Grenoble, France), J. Pepin (Grenoble, France), P. Steiropoulos (Alexandroupolis, Greece), S. Schiza (Heraklion (Crete), Greece). The sleepy phenotype in mild Obstructive  Sleep Apnoea (OSA) patients: from clinical characteristics to cardiometabolic risk. Data from the European Sleep Apnea Database (ESADA).. 2495

Member's Comments

No comment yet.

Related content which might interest you: The sleepy phenotype in mild OSA patients: characteristics and their cardiometabolic risk. Data from the European Sleep Apnea Data Base (ESADA) Source: Virtual Congress 2020 – From respiratory physiology to diagnosis and treatment Year: 2020 Obstructive sleep apnea is an independent predictor for dyslipidemia: Data from the European Sleep Apnea Database (ESADA) Source: International Congress 2017 – Central sleep apnoea: consequences and comorbidities of obstructive sleep apnoea Year: 2017 Determinants of daytime sleepiness in mild obstructive sleep apnoea syndrome. Data from the European Sleep Apnoea Database (ESADA) cohort study. Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities Year: 2018 Obstructive Sleep Apnea (OSAS) in a clinical cohort of children. Atlantis Study Source: International Congress 2017 – What is new in respiratory and sleep physiology? Year: 2017 Residual daytime sleepiness (RES) in CPAP-treated obstructive sleep apnea (OSA) patients in the European Sleep Apnea Database (ESADA) Source: Virtual Congress 2021 – From phenotyping to different diagnostic tools for sleep breathing disorders Year: 2021 The European Sleep Apnoea Database (ESADA): report from 22 European sleep laboratories Source: Eur Respir J 2011; 38: 635-642 Year: 2011 Positional obstructive sleep apnea in the European Sleep Apnoea Database (ESADA) study Source: International Congress 2018 – Treatments that can serve as an alternative to positive airway pressure (PAP) Year: 2018 Change in weight and central obesity by positive airway pressure treatment in obstructive sleep apnea patients: Longitudinal data from the European Sleep Apnea Database (ESADA) Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment Year: 2017 Obstructive Sleep Apnea (OSA) Assessment in the elderly. Preliminary results. Source: International Congress 2018 – Respiratory epidemiology:  from infectious diseases to lung cancer Year: 2018 The prevalence of Obstructive Sleep Apnea (OSA) in patients recovering from COVID-19 Source: Sleep and Breathing Conference 2021 Year: 2021 Smoking status, clinical presentation and outcomes in obstructive sleep apnoea Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters Year: 2014 Sleep apnoea management in Europe during the COVID-19 pandemic: data from the European Sleep Apnoea Database (ESADA) Source: Eur Respir J, 55 (6) 2001323; 10.1183/13993003.01323-2020 Year: 2020 The effect of positive airway pressure on cholesterol in patients with sleep apnea: Data from the European Sleep Apnea Network (ESADA) Source: International Congress 2019 – Current perspectives in sleep-disordered breathing Year: 2019 OSA and cancer in Europe: the European Sleep Apnea Database (ESADA) experience Source: International Congress 2017 – Central sleep apnoea: consequences and comorbidities of obstructive sleep apnoea Year: 2017 Impact of speed and age on an office based advanced driving simulator (MinUoLDS) between obstructive sleep apnoea syndrome (OSAS) patients and controls Source: International Congress 2014 – Sleep disordered breathing 2 Year: 2014 Oral Appliances (OAs) treatment in Obstructive Sleep Apnea (OSA) : a three years experience Source: International Congress 2018 – Treatments that can serve as an alternative to positive airway pressure (PAP) Year: 2018 Prevalence of obstructive sleep apnea syndrome in patients with risk factors for cardiovascular diseases in a large population in Zaragoza (Spain) Source: International Congress 2014 – Sleep disordered breathing 3 Year: 2014 Sleep apnea-hypopnea syndrome (OSA) in elderly Source: International Congress 2014 – Sleep disordered breathing: from children to the elderly Year: 2014 Obstructive sleep apnea and cardiovascular risk markers in community individuals- Results from the sleep apnea and vascular evaluation (SAVE) study Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels Year: 2016 LATE-BREAKING ABSTRACT: Relationship between mild to moderate renal dysfunction and obstructive sleep apnea: data from the European Sleep Apnea Database Source: Annual Congress 2013 –Sleep disordered breathing in special situations III Year: 2013